Lyka Labs Limited (LYKALABS)
ISIN: INE933A01014 Industry: Biotechnology Sector: Healthcare Website
143.5
-4.8(-3.24%)

Lyka Labs Limited engages in the manufacturing and sale of pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. It manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, muscle relaxant, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. The company also provides contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, BA/BE clinical study data, etc. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia, as well as deals in pharmaceutical products. Lyka Labs Limited offers its products in various formulations, including injections, creams, ointments, foams, gels, and lotions. Further, the company exports its products to Bangladesh, Combodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.

Pricing Updates

TODAY'S HIGH

153.6

TODAY'S LOW

140.9

52 WEEK HIGH

267

52 WEEK LOW

50.3

Major Holders

% of Shares Held by
All Insider

54.25%

% of Shares Held by
Institutions

3.53%

% of Float Held by
Institutions

7.71%

Number of Institutions
Holding Shares

1

Company Overview

MARKET CAP

411.70 Cr.

ETERPRISE VALUE

539.65 Cr.

NO. OF SHARES

2.86 Cr.

BOOK VALUE

7.681

DIV. YIELD

None%

DEBT

124.61 Cr.

GROSS PROFIT

29.03 Cr.

CASH

12.56 Cr.

REVENUE

165.42 Cr.

REVENUE/SHARE

57.359

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments0000
Change To Liabilities-4.13 Cr.-6.24 Cr.-1.15 Cr.-14.45 Cr.
Total cashflows from Investing Activities-16.13 Lakhs-10.96 Lakhs-3.97 Cr.-3.16 Cr.
Net Borrowings-4.91 Cr.20.61 Cr.-16.25 Cr.-35.25 Cr.
Total Cash from Financing Activities-11.79 Cr.3.38 Cr.-23.41 Cr.-10.41 Cr.
Other Liabilities-8.86 Cr.8.95 Cr.18.74 Cr.14.08 Cr.
Total Assets02.26 Cr.2.26 Cr.33.55 Cr.
Net Income-11.55 Cr.-60.54 Cr.-5.55 Cr.-17.27 Cr.
Change in Cash-3.14 Cr.8.59 Cr.-72.36 Lakhs-2.69 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities8.81 Cr.5.32 Cr.26.66 Cr.10.88 Cr.
Depreciation7.48 Cr.8 Cr.7.31 Cr.11.28 Cr.
Other Cashflows from Investing Activities1.10 Cr.98.88 Lakhs11.75 Lakhs33.25 Lakhs
Dividends Paid0000
Change to Inventory2.42 Cr.26.95 Lakhs4.19 Cr.2.04 Cr.
Change to Account Receivables-1.06 Cr.7.95 Cr.5.86 Cr.8.67 Cr.
Other Cashflows from Financing Activities-6.88 Cr.-19.50 Cr.-7.16 Cr.-8.70 Cr.
Change to Net Income23.67 Cr.46.91 Cr.-2.74 Cr.6.52 Cr.
Capital Expenditures-1.26 Cr.-1.09 Cr.-4.81 Cr.-3.62 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax-14.14 Cr.-61.87 Cr.-15.42 Cr.-20.04 Cr.
Minority Interest70.43 Lakhs-76.68 Lakhs2.74 Cr.3.35 Cr.
Net Income11.41 Cr.-10.62 Cr.-8.54 Cr.-13.79 Cr.
Selling General Administrative15.56 Cr.15.49 Cr.16.54 Cr.17.68 Cr.
Gross Profit29.03 Cr.20.06 Cr.27.38 Cr.30.40 Cr.
Ebit11.41 Cr.-10.62 Cr.-8.54 Cr.-13.79 Cr.
Operating Income11.41 Cr.-10.62 Cr.-8.54 Cr.-13.79 Cr.
Other Operating Expenses-6.27 Cr.7.18 Cr.12.07 Cr.15.23 Cr.
Interest Expense-25.80 Cr.-19.84 Cr.-6.97 Cr.-7.51 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense-4.05 Cr.74.34 Lakhs-9.07 Cr.-1.03 Cr.
Total Revenue68.51 Cr.56.70 Cr.67.11 Cr.60.37 Cr.
Total Operating Expenses57.09 Cr.67.33 Cr.75.65 Cr.74.17 Cr.
Cost of Revenue39.47 Cr.36.63 Cr.39.72 Cr.29.97 Cr.
Total Other Income Expense Net-25.56 Cr.-51.25 Cr.-6.87 Cr.-6.24 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.-10.09 Cr.-62.62 Cr.-6.35 Cr.-19 Cr.
Net Income Applicable to Common Shares-11.66 Cr.-60.65 Cr.-5.65 Cr.-17.32 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets35.87 Cr.39.73 Cr.44.39 Cr.46.33 Cr.
Capital Surplus97.43 Cr.97.43 Cr.94.96 Cr.94.96 Cr.
Total Liabilities215.10 Cr.215.27 Cr.170.12 Cr.176.35 Cr.
Stock Holder Equity-25.79 Cr.-14.34 Cr.43.01 Cr.49.46 Cr.
Minority Interest70.43 Lakhs-76.68 Lakhs2.74 Cr.3.35 Cr.
Other Liabilities3.28 Cr.8.38 Cr.19.31 Cr.11.15 Cr.
Total Assets190.01 Cr.200.16 Cr.215.88 Cr.229.17 Cr.
Common Stock28.69 Cr.28.69 Cr.28.14 Cr.28.14 Cr.
Retained Earnings-151.91 Cr.-140.36 Cr.-81.09 Cr.-75.89 Cr.
Other Liabilities13.57 Cr.21.13 Cr.6.02 Cr.4.30 Cr.
Good Will0000
Treasury Stock-65 k-10.89 Lakhs1 Cr.2.26 Cr.
Other Assets41.34 Cr.35.42 Cr.44.99 Cr.39.53 Cr.
Cash7.15 Cr.10.30 Cr.1.70 Cr.2.42 Cr.
Current Liabilities49.23 Cr.66.32 Cr.84.81 Cr.167.12 Cr.
Long Term Asset Charges16.34 Cr.12.28 Cr.13.02 Cr.3.95 Cr.
Short Long Term Debt55.40 Lakhs56.42 Lakhs57.82 Lakhs61.66 Cr.
Other Stockholder Equity-65 k-10.89 Lakhs1 Cr.2.26 Cr.
Property Plant Equipment83.65 Cr.89.12 Cr.91.36 Cr.94.01 Cr.
Total Cur. Assets29.12 Cr.35.87 Cr.35.10 Cr.49.06 Cr.
Long Term Investments89 k89 k1.08 Lakhs22.78 Lakhs
Net Tangible Assets-61.66 Cr.-54.07 Cr.-1.38 Cr.3.13 Cr.
Short Term Investments93.52 Lakhs1.97 Cr.3.73 Cr.3.79 Cr.
Net Receivables10.74 Cr.9.79 Cr.16.34 Cr.21.11 Cr.
Long Term Debt151.05 Cr.125.66 Cr.78.79 Cr.4.67 Cr.
Inventory4.30 Cr.6.73 Cr.7 Cr.11.19 Cr.
Accounts Payable22.08 Cr.27.11 Cr.32.77 Cr.34.45 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account